Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFJK NASDAQ:GROW NASDAQ:INAC NASDAQ:JYNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFJKAimei Health Technology$41.52-8.4%$38.22$6.75▼$130.37$131.45M0.4621,726 shs1,064 shsGROWU.S. Global Investors$2.62-1.5%$2.67$2.20▼$3.65$32.50M0.7147,459 shs21,040 shsINACIndigo Acquisition$10.23+0.2%$10.17$9.92▼$10.24$131.46MN/A15,988 shs20,103 shsJYNTJoint$9.16-1.5%$8.72$7.50▼$13.47$130.62M1.1163,796 shs55,752 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFJKAimei Health Technology+7.20%+1.68%-2.65%+32.71%+284.57%GROWU.S. Global Investors+1.14%+0.76%+3.91%-20.12%+21.46%INACIndigo Acquisition+0.29%+0.48%+0.59%+1.18%+1,024,999,900.00%JYNTJoint+0.87%+6.29%+2.42%+1.31%-7.92%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFJKAimei Health Technology$41.52-8.4%$38.22$6.75▼$130.37$131.45M0.4621,726 shs1,064 shsGROWU.S. Global Investors$2.62-1.5%$2.67$2.20▼$3.65$32.50M0.7147,459 shs21,040 shsINACIndigo Acquisition$10.23+0.2%$10.17$9.92▼$10.24$131.46MN/A15,988 shs20,103 shsJYNTJoint$9.16-1.5%$8.72$7.50▼$13.47$130.62M1.1163,796 shs55,752 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFJKAimei Health Technology+7.20%+1.68%-2.65%+32.71%+284.57%GROWU.S. Global Investors+1.14%+0.76%+3.91%-20.12%+21.46%INACIndigo Acquisition+0.29%+0.48%+0.59%+1.18%+1,024,999,900.00%JYNTJoint+0.87%+6.29%+2.42%+1.31%-7.92%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFJKAimei Health Technology 1.00SellN/AN/AGROWU.S. Global Investors 2.00HoldN/AN/AINACIndigo Acquisition 1.00SellN/AN/AJYNTJoint 2.33Hold$18.0096.51% UpsideCurrent Analyst Ratings BreakdownLatest GROW, INAC, JYNT, and AFJK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026JYNTJoint Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D) ➝ Sell (D+)5/12/2026JYNTJoint Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/6/2026JYNTJoint Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)4/13/2026JYNTJoint Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/1/2026INACIndigo Acquisition Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSell (D-)3/27/2026AFJKAimei Health Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)3/13/2026JYNTJoint Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 5/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFJKAimei Health TechnologyN/AN/A$0.52 per share80.23($1.91) per shareN/AGROWU.S. Global Investors$9.48M3.43N/AN/A$3.71 per share0.71INACIndigo AcquisitionN/AN/AN/AN/AN/AN/AJYNTJoint$54.90M2.38$0.10 per share94.79$1.09 per share8.40Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFJKAimei Health Technology$1.06M$0.18230.67N/AN/AN/A-33.32%2.91%N/AGROWU.S. Global Investors-$330K$0.2610.08N/AN/A33.29%6.92%6.51%N/AINACIndigo AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AN/AJYNTJoint$2.91M$0.2339.8314.54N/A5.72%7.00%2.05%8/6/2026 (Estimated)Latest GROW, INAC, JYNT, and AFJK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q3 2026GROWU.S. Global InvestorsN/A$0.23N/A$0.23N/A$2.76 million5/11/2026Q1 2026INACIndigo AcquisitionN/A$0.06N/A$0.06N/AN/A5/7/2026Q1 2026JYNTJoint$0.03$0.08+$0.05$0.09$14.50 million$14.82 million5/4/2026Q4 2025AFJKAimei Health TechnologyN/A$0.02N/A$0.02N/AN/A3/25/2026Q4 2025INACIndigo AcquisitionN/A$0.09N/A$0.09N/AN/A3/12/2026Q4 2025JYNTJoint$0.05$0.07+$0.02$0.07$14.12 million$15.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAFJKAimei Health TechnologyN/AN/AN/AN/AN/AGROWU.S. Global Investors$0.093.44%+24.57%34.62%N/AINACIndigo AcquisitionN/AN/AN/AN/AN/AJYNTJointN/AN/AN/AN/AN/ALatest GROW, INAC, JYNT, and AFJK DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/2/2026GROWU.S. Global Investorsmonthly$0.00752.79%6/15/20266/15/20266/29/20263/2/2026GROWU.S. Global Investorsmonthly$0.00753.57%5/11/20265/11/20265/26/20263/2/2026GROWU.S. Global Investorsmonthly$0.00753.57%4/13/20264/13/20264/27/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFJKAimei Health TechnologyN/AN/AN/AGROWU.S. Global InvestorsN/A20.9115.33INACIndigo AcquisitionN/AN/AN/AJYNTJointN/A1.641.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFJKAimei Health Technology45.58%GROWU.S. Global Investors23.62%INACIndigo AcquisitionN/AJYNTJoint76.88%Insider OwnershipCompanyInsider OwnershipAFJKAimei Health Technology2.50%GROWU.S. Global Investors19.19%INACIndigo AcquisitionN/AJYNTJoint30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFJKAimei Health TechnologyN/A3.17 million3.09 millionN/AGROWU.S. Global Investors2012.40 million10.02 millionOptionableINACIndigo Acquisition212.85 millionN/AN/AJYNTJoint32014.26 million9.95 millionOptionableGROW, INAC, JYNT, and AFJK HeadlinesRecent News About These CompaniesThe Joint: Can Refranchising Unlock A Better Business?May 26 at 11:01 AM | seekingalpha.comJoint Shareholders Approve Board Slate, Executive Pay at 2026 Annual MeetingMay 26 at 4:05 AM | americanbankingnews.comJoint (NASDAQ:JYNT) Stock Crosses Above 50-Day Moving Average - What's Next?May 22, 2026 | americanbankingnews.comThe Joint Corp. Announces Milind Pant Elected as DirectorMay 21, 2026 | globenewswire.comInsider Buying: Joint (NASDAQ:JYNT) Major Shareholder Acquires $1,094,183.32 in StockMay 17, 2026 | americanbankingnews.comJoint (NASDAQ:JYNT) Major Shareholder Charles Jobson Buys 127,676 SharesMay 15, 2026 | insidertrades.comJoint Corp ten percent owner Charles Jobson buys $1.27M in sharesMay 14, 2026 | investing.comJoint (NASDAQ:JYNT) Announces Quarterly Earnings ResultsMay 9, 2026 | marketbeat.comJoint (NASDAQ:JYNT) Raised to Buy at Wall Street ZenMay 9, 2026 | marketbeat.comThe Joint (JYNT) Q1 2026 Earnings TranscriptMay 8, 2026 | finance.yahoo.comJoint (NASDAQ:JYNT) Shares Cross Below 200-Day Moving Average - Here's What HappenedMay 8, 2026 | marketbeat.comJoint Q1 Earnings Call HighlightsMay 8, 2026 | marketbeat.comThe Joint Corp. (JYNT) Beats Q1 Earnings and Revenue EstimatesMay 7, 2026 | zacks.comJoint Corp Amends Credit Facility, Enhances Capital FlexibilityMay 7, 2026 | tipranks.comThe Joint Corp. Reports First Quarter 2026 Financial ResultsMay 7, 2026 | globenewswire.comThe Joint Corp (JYNT) Q1 2026 Earnings Report Preview: What To ExpectMay 6, 2026 | finance.yahoo.comCigna (CI) Q1 Earnings and Revenues Beat EstimatesApril 30, 2026 | zacks.comJoint (JYNT) to Release Earnings on ThursdayApril 30, 2026 | marketbeat.comCentene (CNC) Tops Q1 Earnings and Revenue EstimatesApril 28, 2026 | zacks.comThe Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern CaliforniaApril 27, 2026 | globenewswire.comThe Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and WebcastApril 23, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesIonQ Just Posted a Breakout Quarter—But 1 Problem RemainsBy Nathan Reiff | May 7, 2026Roblox Stock Slides to New Low as Safety Changes Weigh on OutlookBy Jennifer Ryan Woods | May 3, 2026Robinhood, SoFi, and Webull Are Telling Very Different StoriesBy Peter Frank | May 17, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026Microsoft Earnings Look Strong, But Investors Focus on RisksBy Chris Markoch | April 30, 2026GROW, INAC, JYNT, and AFJK Company DescriptionsAimei Health Technology NASDAQ:AFJK$41.52 -3.80 (-8.38%) Closing price 04:00 PM EasternExtended Trading$41.90 +0.38 (+0.92%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.U.S. Global Investors NASDAQ:GROW$2.62 -0.04 (-1.50%) Closing price 04:00 PM EasternExtended Trading$2.62 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.U.S. Global Investors, Inc. is a publicly owned investment manager. It primarily provides its services to investment companies. The firm is a large advisory firm, an investment adviser to an investment company which provides portfolio management for investment companies. The firm manages and launches equity/balanced funds, fixed income funds and other funds. It also manages hedge funds. The firm primarily invests in no-load mutual funds and exchange traded funds (ETFs). U.S. Global Investors, Inc. is based in San Antonio, Texas.Indigo Acquisition NASDAQ:INAC$10.25 +0.04 (+0.39%) As of 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more.We are a blank check company incorporated on June 7, 2024 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, which we refer to throughout this prospectus as our “business combination” or “initial business combination,” with one or more businesses or entities, which we refer to throughout this prospectus as a “target business” or “target businesses”. We are not limited to target businesses in any specific industry or geographic location, although we intend to focus on opportunities with established, profitable companies with attractive market positions and/or growth potential that can leverage our management team’s experience and expertise. We have generated no revenues to date and we do not expect that we will generate operating revenues until, at the earliest, we consummate our initial business combination. We have not selected any specific target business and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any target business with respect to an initial business combination with us. Our Objectives Our objective is to identify and acquire an established, profitable company with strong fundamentals and significant upside potential. We seek to partner with a business that can benefit from our management team’s strategic guidance and industry relationships, and our company’s access to the public capital markets. We aim to create long-term value for our shareholders through the successful completion of a business combination and the subsequent growth of the acquired business. Our executive office is located in Miami, Florida.Joint NASDAQ:JYNT$9.16 -0.14 (-1.51%) Closing price 04:00 PM EasternExtended Trading$9.18 +0.02 (+0.16%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Snowflake and the Snowballing Impact of its AI Flywheel IREN Is Flipping the Switch from Bitcoin to AI 3 Stocks Rallying on Micron's Price Boost: Substance or Hype? This Quantum Computing Stock May Be Closer to a Breakout Than You Think Microsoft Is Spending Billions on AI, But Investors Aren’t Buying It AI’s Biggest Bottleneck Could Make These 2 Stocks Soar If the Market Rally Stalls, This ETF Can Insulate Portfolios RTX Is Set to Revolutionize Munitions Manufacturing Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
